AxImmune's Grant

AxImmune raised a round of funding on May 18, 2018. Investors include Colorado Office of Economic Development and International Trade.

AxImmune is developing clinical stage immuno-oncology (IO) technology in-licensed from Colorado State University (CSU) and other parties.…

Articles about AxImmune's Grant: